| manager |
|
| language |
- |
| license |
- |
| created at |
2017-12-21 11:07:16 UTC |
| updated at |
2017-12-21 12:22:32 UTC |
|
2 layers
|
143,100 entries
|
There is 0 pattern entry.
|
Special Protocol Assessment Request: Carcinogenicity Study
|
CONC:NCI_FDA |
|
|
Special Protocol Assessment Request: Clinical Study
|
CONC:NCI_FDA |
|
|
Special Protocol Assessment Request: Stability Study
|
CONC:NCI_FDA |
|
|
Drug Product: Stability Summary And Conclusion
|
CONC:NCI_FDA |
|
|
Drug Substance: Stability Summary And Conclusions
|
CONC:NCI_FDA |
|
|
Description And Composition Of The Drug Product
|
CONC:NCI_FDA |
|
|
Drug Substance: Description Of Manufacturing Process And Process Controls
|
CONC:NCI_FDA |
|
|
Statement Of Right Of Reference
|
CONC:NCI_FDA |
|
|
Status Of Other Postmarketing Studies
|
CONC:NCI_FDA |
|
|
Status Of Postmarketing Study Commitments
|
CONC:NCI_FDA |
|
|
Study Reports And Related Information Of Controlled Clinical Studies Pertinent To The Claimed Indication [Type Of Control]
|
CONC:NCI_FDA |
|
|
Study Reports And Related Information Of Uncontrolled Clinical Studies
|
CONC:NCI_FDA |
|
|
Pharmacokinetics: Excretion
|
CONC:NCI_FDA |
|
|
Module 4: Pharmacology
|
CONC:NCI_FDA |
|
|
Study Reports: Toxicology
|
CONC:NCI_FDA |
|
